Pay in 4 interest-free payments of $40.50 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
2020 Mar 27
Remodelin was used at 1-10 µM in vitro and cellular assays
is a quinolone-derived sphingomyelin synthase inhibitor that blocks P-glycoprotein and multidrug resistance-associated protein-1
Valrubicin in combination with radiation enhances the cytotoxicity
Azone markedly fluidized liposomal lipids (as a model lipid system) compared with other enhancers
NV-5138 C AR Degrader-4 TFA 2020 Mar 27NV 5138 is an orally and centrally active small molecule drug for the treatment of major depressive disorder (MDD). It directly and selectively activates the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway by binding to and modulating sestrin2, a leucine amino acid sensor and upstream regulatory pathway. The mTORC1 pathway is the same signaling pathway that the NMDA receptor antagonist ketamine activates in the medial prefrontal
US$ 199.99
US$ 130.50
US$ 122.00
US$ 377.50